Dachaigh › Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil › Connecticut › New Haven
Sgrùdaidhean clionaigeach Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil ann an New Haven, CT
Tha 22 sgrùdaidhean airson Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil a’ lorg phàirtichean aig làraichean ann agus timcheall air New Haven (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #62, New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
A’ fastadhÌre 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
A’ fastadhÌre 1
- Yale University - Yale University School of Medicine, New Haven
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A’ fastadhÌre 3
- Yale Cancer Center, New Haven
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
A’ fastadhÌre 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Yale University, Yale Cancer Center, New Haven
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
A’ fastadhÌre 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mìle air falbh
- agus 1 a bharrachd
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
A’ fastadhÌre 1
- Yale University Cancer Center, New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
A’ fastadhÌre 1
- Normunity Investigational Site, New Haven
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
A’ fastadhÌre 2/3
- Yale University, New Haven
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
- Yale University, New Haven
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
A’ fastadhÌre 1/2
- Yale Comprehensive Cancer Center, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Yale University, Yale Cancer Center, New Haven
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
A’ fastadhÌre 2
- Yale University, New Haven
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
A’ fastadhÌre 1
- Yale University School of Medicine /ID# 225707, New Haven
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
A’ fastadhÌre 3
- GSK Investigational Site, New Haven
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
A’ fastadhÌre 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
A’ fastadhÌre 2
- Yale, New Haven
Sgrùdaidhean Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil ann am bailtean eile
- Houston, TX47 sgrùdaidhean
- Los Angeles, CA42 sgrùdaidhean
- Boston, MA40 sgrùdaidhean
- New York City, NY39 sgrùdaidhean
- Nashville, TN39 sgrùdaidhean
- St. Louis, MO28 sgrùdaidhean
- Arlington, VA26 sgrùdaidhean
- Philadelphia, PA26 sgrùdaidhean
- Chicago, IL26 sgrùdaidhean
- Atlanta, GA24 sgrùdaidhean
- San Antonio, TX22 sgrùdaidhean
- Pittsburgh, PA22 sgrùdaidhean
Sgrùdaidhean eile ann an New Haven
- Aillse Sgamhain Neo-chealla-beag41 sgrùdaidhean
- Aillse a' bhroilleach38 sgrùdaidhean
- Aillse (gach seòrsa)33 sgrùdaidhean
- Ailse metastatach23 sgrùdaidhean
- Ailseachadh nan Sgamhan22 sgrùdaidhean
- Cancer Ovarian21 sgrùdaidhean
- Aillse colorectal20 sgrùdaidhean
- Aillse Prostata20 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Disorder of Alcohol Use (AUD)17 sgrùdaidhean
- Overdose Opioid17 sgrùdaidhean
- Cancer Pancreatic16 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.